Global and United States Oncology Based In-vivo CRO Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Oncology Based In-vivo CRO Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Blood cancer
  • 1.2.3 Solid tumors
  • 1.2.4 Other
• 1.3 Market by Application
  • 1.3.1 Global Oncology Based In-vivo CRO Market Share by Application: 2020 VS 2026
  • 1.3.2 Hospitals
  • 1.3.3 Rehabilitation Centers
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Oncology Based In-vivo CRO Market Perspective (2015-2026)
• 2.2 Global Oncology Based In-vivo CRO Growth Trends by Regions
  • 2.2.1 Oncology Based In-vivo CRO Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Oncology Based In-vivo CRO Historic Market Share by Regions (2015-2020)
  • 2.2.3 Oncology Based In-vivo CRO Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Oncology Based In-vivo CRO Players by Market Size
  • 3.1.1 Global Top Oncology Based In-vivo CRO Players by Revenue (2015-2020)
  • 3.1.2 Global Oncology Based In-vivo CRO Revenue Market Share by Players (2015-2020)
• 3.2 Global Oncology Based In-vivo CRO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Oncology Based In-vivo CRO Revenue
• 3.4 Global Oncology Based In-vivo CRO Market Concentration Ratio
  • 3.4.1 Global Oncology Based In-vivo CRO Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Oncology Based In-vivo CRO Revenue in 2019
• 3.5 Key Players Oncology Based In-vivo CRO Area Served
• 3.6 Key Players Oncology Based In-vivo CRO Product Solution and Service
• 3.7 Date of Enter into Oncology Based In-vivo CRO Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Based In-vivo CRO Breakdown Data by Type (2015-2026)

• 4.1 Global Oncology Based In-vivo CRO Historic Market Size by Type (2015-2020)
• 4.2 Global Oncology Based In-vivo CRO Forecasted Market Size by Type (2021-2026)

5 Oncology Based In-vivo CRO Breakdown Data by Application (2015-2026)

• 5.1 Global Oncology Based In-vivo CRO Historic Market Size by Application (2015-2020)
• 5.2 Global Oncology Based In-vivo CRO Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Oncology Based In-vivo CRO Market Size (2015-2026)
• 6.2 North America Oncology Based In-vivo CRO Market Size by Type (2015-2020)
• 6.3 North America Oncology Based In-vivo CRO Market Size by Application (2015-2020)
• 6.4 North America Oncology Based In-vivo CRO Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Oncology Based In-vivo CRO Market Size (2015-2026)
• 7.2 Europe Oncology Based In-vivo CRO Market Size by Type (2015-2020)
• 7.3 Europe Oncology Based In-vivo CRO Market Size by Application (2015-2020)
• 7.4 Europe Oncology Based In-vivo CRO Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Oncology Based In-vivo CRO Market Size (2015-2026)
• 8.2 China Oncology Based In-vivo CRO Market Size by Type (2015-2020)
• 8.3 China Oncology Based In-vivo CRO Market Size by Application (2015-2020)
• 8.4 China Oncology Based In-vivo CRO Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Oncology Based In-vivo CRO Market Size (2015-2026)
• 9.2 Japan Oncology Based In-vivo CRO Market Size by Type (2015-2020)
• 9.3 Japan Oncology Based In-vivo CRO Market Size by Application (2015-2020)
• 9.4 Japan Oncology Based In-vivo CRO Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Oncology Based In-vivo CRO Market Size (2015-2026)
• 10.2 Southeast Asia Oncology Based In-vivo CRO Market Size by Type (2015-2020)
• 10.3 Southeast Asia Oncology Based In-vivo CRO Market Size by Application (2015-2020)
• 10.4 Southeast Asia Oncology Based In-vivo CRO Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Crown Bioscience
  • 11.1.1 Crown Bioscience Company Details
  • 11.1.2 Crown Bioscience Business Overview
  • 11.1.3 Crown Bioscience Oncology Based In-vivo CRO Introduction
  • 11.1.4 Crown Bioscience Revenue in Oncology Based In-vivo CRO Business (2015-2020))
  • 11.1.5 Crown Bioscience Recent Development
• 11.2 Charles River Laboratory
  • 11.2.1 Charles River Laboratory Company Details
  • 11.2.2 Charles River Laboratory Business Overview
  • 11.2.3 Charles River Laboratory Oncology Based In-vivo CRO Introduction
  • 11.2.4 Charles River Laboratory Revenue in Oncology Based In-vivo CRO Business (2015-2020)
  • 11.2.5 Charles River Laboratory Recent Development
• 11.3 ICON Plc.
  • 11.3.1 ICON Plc. Company Details
  • 11.3.2 ICON Plc. Business Overview
  • 11.3.3 ICON Plc. Oncology Based In-vivo CRO Introduction
  • 11.3.4 ICON Plc. Revenue in Oncology Based In-vivo CRO Business (2015-2020)
  • 11.3.5 ICON Plc. Recent Development
• 11.4 Eurofins Scientific
  • 11.4.1 Eurofins Scientific Company Details
  • 11.4.2 Eurofins Scientific Business Overview
  • 11.4.3 Eurofins Scientific Oncology Based In-vivo CRO Introduction
  • 11.4.4 Eurofins Scientific Revenue in Oncology Based In-vivo CRO Business (2015-2020)
  • 11.4.5 Eurofins Scientific Recent Development
• 11.5 Taconic Biosciences
  • 11.5.1 Taconic Biosciences Company Details
  • 11.5.2 Taconic Biosciences Business Overview
  • 11.5.3 Taconic Biosciences Oncology Based In-vivo CRO Introduction
  • 11.5.4 Taconic Biosciences Revenue in Oncology Based In-vivo CRO Business (2015-2020)
  • 11.5.5 Taconic Biosciences Recent Development
• 11.6 Covance
  • 11.6.1 Covance Company Details
  • 11.6.2 Covance Business Overview
  • 11.6.3 Covance Oncology Based In-vivo CRO Introduction
  • 11.6.4 Covance Revenue in Oncology Based In-vivo CRO Business (2015-2020)
  • 11.6.5 Covance Recent Development
• 11.7 EVOTEC
  • 11.7.1 EVOTEC Company Details
  • 11.7.2 EVOTEC Business Overview
  • 11.7.3 EVOTEC Oncology Based In-vivo CRO Introduction
  • 11.7.4 EVOTEC Revenue in Oncology Based In-vivo CRO Business (2015-2020)
  • 11.7.5 EVOTEC Recent Development
• 11.8 The Jackson Laboratory
  • 11.8.1 The Jackson Laboratory Company Details
  • 11.8.2 The Jackson Laboratory Business Overview
  • 11.8.3 The Jackson Laboratory Oncology Based In-vivo CRO Introduction
  • 11.8.4 The Jackson Laboratory Revenue in Oncology Based In-vivo CRO Business (2015-2020)
  • 11.8.5 The Jackson Laboratory Recent Development
• 11.9 Wuxi AppTec.
  • 11.9.1 Wuxi AppTec. Company Details
  • 11.9.2 Wuxi AppTec. Business Overview
  • 11.9.3 Wuxi AppTec. Oncology Based In-vivo CRO Introduction
  • 11.9.4 Wuxi AppTec. Revenue in Oncology Based In-vivo CRO Business (2015-2020)
  • 11.9.5 Wuxi AppTec. Recent Development
• 11.10 MI Bioresearch, Inc.
  • 11.10.1 MI Bioresearch, Inc. Company Details
  • 11.10.2 MI Bioresearch, Inc. Business Overview
  • 11.10.3 MI Bioresearch, Inc. Oncology Based In-vivo CRO Introduction
  • 11.10.4 MI Bioresearch, Inc. Revenue in Oncology Based In-vivo CRO Business (2015-2020)
  • 11.10.5 MI Bioresearch, Inc. Recent Development
• 11.11 Living Tumor Laboratory
  • 10.11.1 Living Tumor Laboratory Company Details
  • 10.11.2 Living Tumor Laboratory Business Overview
  • 10.11.3 Living Tumor Laboratory Oncology Based In-vivo CRO Introduction
  • 10.11.4 Living Tumor Laboratory Revenue in Oncology Based In-vivo CRO Business (2015-2020)
  • 10.11.5 Living Tumor Laboratory Recent Development
• 11.12 Champion Oncology, Inc.
  • 10.12.1 Champion Oncology, Inc. Company Details
  • 10.12.2 Champion Oncology, Inc. Business Overview
  • 10.12.3 Champion Oncology, Inc. Oncology Based In-vivo CRO Introduction
  • 10.12.4 Champion Oncology, Inc. Revenue in Oncology Based In-vivo CRO Business (2015-2020)
  • 10.12.5 Champion Oncology, Inc. Recent Development
• 11.13 Xentech
  • 10.13.1 Xentech Company Details
  • 10.13.2 Xentech Business Overview
  • 10.13.3 Xentech Oncology Based In-vivo CRO Introduction
  • 10.13.4 Xentech Revenue in Oncology Based In-vivo CRO Business (2015-2020)
  • 10.13.5 Xentech Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer